The Drug Eluting Balloons (DEB) market is inflating rapidly, projected to reach over a billion dollars by 2031. This growth is driven by the increasing popularity of minimally invasive treatments for heart disease. Patients are opting for faster recovery times and less scarring offered by DEB angioplasty compared to traditional bypass surgery. Additionally, the rising prevalence of...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian